For the fifth time in succession, Biomax data mining subsidiary, Viscovery, reports a significant net profit for the last fiscal year. The equity ratio rose to 45%. Business in the life sciences continue to develop very well, whereby the share of joint offering projects in total revenues increased again in 2016.
In cooperation with its parent company, Biomax, ongoing projects with international clients have successfully been continued. Several new license customers were gained, including First Quantum Minerals in Australia, Kojima Industries Corporation in Japan, and the International Finance Corporation in USA, as well as numerous universities worldwide. In addition to the Deloitte consulting group, PricewaterhouseCoopers has now also chosen Viscovery® SOMine for their analytics services.